Active Startup: nPlex Biosciences

News

Published: 9Oct2019

Business Snapshot
The company is leveraging nanotechnology to develop smart, programmable reagents that address longstanding challenges in multiplexed protein quantification.

Target Markets
Research and pharmaceutical.

Intellectual Property
Patent application in the US, PCT patent application

Founders
Milad Dagher, David Juncker